NYU Langone's Neuromodulation Center offers innovative treatment for movement disorders, chronic pain and other neurological conditions through targeted stimulation technology, navigation techniques.
Researchers at NYU School of Medicine have, for the first time, identified a single gene that simultaneously controls inflammation, accelerated aging and cancer.
The NYU School of Medicine will host a special screening of GIGANTE, a documentary about Andrés “Yungo” Torres, a Puerto Rican professional baseball player currently with the New York Mets and his struggles with acute ADHD. It revisits the pivotal years of his childhood in flashbacks interpreted by children culled from the humble Western Puerto Rican neighborhood where Yungo was raised and flashes forward between his last year as a San Francisco Giant and his new beginning with the Mets. Starring his teammates, coaches, family, and the luminaries of ADHD research, GIGANTE aims to put a light on the man who has achieved so much in spite of one of the most acute manifestations of the disorder. Part cautionary tale, part biopic, it aims to inform, enlighten and inspire.
As part of its plan to expand access to a wide array of outpatient services, NYU Langone Medical Center has opened a new 327,000 square-foot Ambulatory Care Center (ACC) at 240 East 38th Street.
A team of urological surgeons from NYU Langone Medical Center performed a robotic-assisted partial nephrectomy in New York and beamed the procedure from New York via high definition satellite to more than 400 participants attending the American Urological Association’s (AUA) 2012 Annual Meeting in Atlanta earlier this week. The surgery showcased the advanced robotic technology available to patients at the Robotic Surgery Center at NYU Langone.
If the first month at NYU Langone’s new Center for Musculoskeletal Care (CMC) is any indication of the growing need for integrated care, the more than 16,000 patients coming to the facility since it opened in April is a true testament.
New York University School of Medicine will hold its 170th annual graduation at 10am, Thursday, May 17, 2012, at Avery Fisher Hall at Lincoln Center for the Performing Arts in Manhattan. Arthur L. Caplan, PhD, Sidney D. Caplan Professor of Bioethics at the University of Pennsylvania, Perelman School of Medicine in Pennsylvania will deliver the keynote address entitled “Physician Advocacy in a Changing Health Care Environment.”
Arthritis month highlights importance of clinical expertise, research and technology to aid in earlier identification of joint diseases, better long-term outcomes.
NYU Langone’s Multiple Sclerosis (MS) Comprehensive Care Center recently opened the doors to a new clinical practice – the first to occupy NYU Langone Medical Center’s new, nearly 300,000-square-foot Ambulatory Care Center.
Neurosurgeons from NYU Langone Medical Center will present research and discuss surgical approaches and use of new technologies to treat neurosurgical conditions at the annual meeting of the American Association of Neurological Surgeons (AANS), held April 14-18, 2012 in Miami Beach, FL.
In the current hyper-charged United States healthcare debate, the focus on lowering cost without compromising quality of care remains a priority. But according to a new study by researchers at NYU Langone Medical Center and colleagues, one common approach may have serious unintended consequences.
The Biotechnology Study Center of NYU School of Medicine will hold its 12th annual awards symposium on April 9, 2012, to honor three outstanding leaders in biomedical research. The Dart/NYU Biotechnology Achievement Awards recognize the role of pure science in the development of pharmaceuticals and honors those scientists whose work has led to major advances to improving care provided at the patient’s bedside.
Lawrence Leichman, MD, and Cynthia Gail Leichman, MD, have been appointed faculty members of the Department of Medicine, Division of Hematology and Medical Oncology at NYU Langone Medical Center.
Events Highlight Brain Injury Awareness Month; NYU Langone clinicians and researchers committed to reducing the incidence of injury and improving the lives of those living with brain injuries.
A new study by researchers at NYU Langone Medical Center reveals that the presence of Helicobacter pylori (H. pylori) bacteria is associated with elevated levels of glycosylated hemoglobin (HbA1c), an important biomarker for blood glucose levels and diabetes. The association was even stronger in obese individuals with a higher Body Mass Index (BMI). The results, which suggest the bacteria may play a role in the development of diabetes in adults, are available online in The Journal of Infectious Diseases.
A new research survey conducted by the Center for the Study of Asian American Health at NYU Langone Medical Center shows the Bangladeshi community in New York City experiences numerous barriers to diabetes care because of limited English proficiency and lack of diabetes awareness.
Launched just nine months ago, more than125,000 patients at NYU Langone Medical Center are now using PatientSecure™, a cutting-edge biometric identification system. PatientSecure enhances the security of electronic health records (EHR) by quickly and accurately “linking” the right record to the right patient at check-in and registration. The technology works in conjunction with NYU Langone Medical Center’s integrated EHR system, Epic, providing a single platform from which physicians, staff and patients themselves can access and manage medical information.
USA Wrestling, the national governing body for amateur wrestling in the United States, announced today that the Department of Orthopaedic Surgery at NYU Langone Medical Center is an official sponsor and medical consultant.
A nutrient found in the dark meat of poultry may provide protection against coronary heart disease (CHD) in women with high cholesterol, according to a study by researchers at NYU Langone Medical Center.
Voluminous research literature attests to the multiple negative consequences of maternal depression and depressive symptoms for the health and development of children. In contrast, there is a profound paucity of information about depressive symptoms in fathers according to a follow up study by NYU School of Medicine researchers in the February 23rd online edition of Maternal and Child Health Journal.
A novel discovery by researchers at NYU Langone Medical Center and colleagues reveals a mechanism by which the immune system tries to halt the spread of HIV. Harnessing this mechanism may open up new paths for therapeutic research aimed at slowing the virus’ progression to AIDS. The study appears online ahead of print today in Nature Immunology.
Patients and health care professionals can learn about the commitment to world-class care and operational transparency in the Department of Orthopaedic Surgery’s recently published “2012 Quality and Outcomes Report.”
Experts from the Department of Orthopaedic Surgery at NYU Langone Medical Center will present their latest research and clinical findings on diseases of the muscle, tendon, bone and joint at the annual meeting of the American Academy of Orthopaedic Surgeons (AAOS), February 7-11 in San Francisco, California.
Programs that support parents during their child’s early years hold promise for obesity prevention, according to a new study in the online February 6 issue of Pediatrics.
Ralph A. Nixon, PhD, MD, professor in the Departments of Psychiatry and Cell Biology, director of the NYU Center of Excellence on Brain Aging and the Silberstein Alzheimer’s Institute at NYU Langone Medical Center has been named chair of the Alzheimer’s Association Medical and Scientific Advisory Council (MSAC) and has also been appointed to the Association’s national Board of Directors.
A new study by researchers at NYU Langone Medical Center and colleagues found that traditional risk factors for stroke – such as high cholesterol – are not as accurate at predicting risk in postmenopausal women as previously thought. Instead, researchers say doctors should refocus their attention on triglyceride levels to determine which women are at highest risk of suffering a devastating and potentially fatal cardiovascular event.
A new study by NYU Langone Medical Center and Northwestern University Feinberg School of Medicine shows novel PSA velocity (PSAV) risk count testing may provide a more effective way for physicians to screen men for clinically significant prostate cancer.
NYU School of Medicine announced the creation of a new Department of Population Health focused on research to improve human health at the population level. Marc Gourevitch, MD, MPH, professor of population health and medicine at NYU School of Medicine was appointed inaugural chair.
When it comes to taking prescribed medications for hypertension, a patient’s self confidence could be as important as doctor’s orders. A new study by researchers at NYU School of Medicine reveals that positive affirmation, when coupled with patient education, seems to help patients more effectively follow their prescribed medication regimen.
A new study published in the journal Nature Medicine by NYU Cancer Institute researchers, shows how the cancer causing gene Notch, in combination with a mutated Polycomb Repressive Complex 2 (PRC2) protein complex, work together to cause T- cell acute lymphoblastic leukemia (T-ALL).
A new study by NYU Langone Medical Center researchers identified a new culprit that leads to atherosclerosis, the accumulation of fat and cholesterol that hardens into plaque and narrows arteries. The research explains why cholesterol-laden, coronary artery disease-causing cells called macrophages, accumulate in artery plaques.
In a new study, NYU Langone Medical Center researchers have discovered how cholesterol-lowering drugs called statins promote the breakdown of plaque in the arteries.
Experts from the NYU Cancer Institute, an NCI-designated cancer center at NYU Langone Medical Center, presented their latest research findings about hematologic cancers at the 53rd ASH Annual Meeting and Exposition held December 10-13, 2011 in San Diego, California. Significant research news was shared about lymphomas, Acute Lymphoblastic Leukemia (ALL) and multiple myeloma.
NYU Langone Medical Center announced today that 14 new medical and surgical pediatric sub-specialists have been appointed to the faculty across eight specialties, including cardiac critical care, emergency medicine and otolaryngology.
Seth Orlow, MD, PhD, professor and chair of the Ronald O. Perelman Department of Dermatology at NYU Langone Medical Center recently announced the appointment of 5 new faculty members. The appointments represent a 30% increase in NYU’s Dermatology Faculty Group Practice and are part of a major expansion taking place at one of the oldest dermatology departments in the United States.
John G. Golfinos, MD, was honored on Friday night as the “Distinguished Physician” by the Hellenic Medical Society (HMS) of New York during its 75th Annual Scholarship Gala.
Jacqueline A. French, MD, professor of neurology and director of translational research and clinical trials at the Comprehensive Epilepsy Center at NYU Langone Medical Center, was named first vice president of the American Epilepsy Society (AES) during the 65th annual meeting.
Doctors of the Dark Side (www.doctorsofthedarkside.com) documents the critical role of physicians and psychologists in the torture of detainees in US custody.
The Cardiac & Vascular Institute at NYU Langone Medical Center has established its new LVAD Program. This surgical intervention program offers eligible, advanced heart failure patients implantation of the latest, lifesaving tool – a left ventricular assist device (LVAD). NYU Langone offers the only FDA approved LVAD device for advanced heart failure.
The study led by Dr. Charles Marmar, professor and chair of the Department of Psychiatry at the NYU Langone Medical Center, is one of the largest to identify a possible method for predicting vulnerability to stress during and after a traumatic event.
Experts from the Department of Radiology at NYU Langone Medical Center will present new research and advanced imaging techniques at the 97th Scientific Assembly and Annual Meeting of the Radiology Society of North America (RSNA) in Chicago, November 27 - December 2, 2011.
Researchers from the NYU Cancer Institute, an NCI-designated cancer center at NYU Langone Medical Center, have discovered a new potential therapeutic target for Diffuse Large B-Cell Lymphoma (DLBCL), the most aggressive and common type of lymphoma in adults. The new study, published in the November 23 issue of Nature, reveals the underlying molecular mechanism contributing to the development of lymphomagenesis.
NYU Langone Medical Center researchers have discovered the novel protective role dendritic cells play in the pancreas. The new study, published in the November issue of journal Gastroenterology, shows dendritic cells can safeguard the pancreas against acute pancreatitis, a sudden dangerous swelling and inflammation of the pancreas gland.
In a new study scientists at NYU Langone Medical Center have shown that the sense of smell can be improved. The new findings, published online November 20, 2011, in Nature Neuroscience, suggest possible ways to reverse the loss of smell due to aging or disease.